Atrophy of hypothalamic subregions increases migraine risk: cross-sectional study and mendelian randomization analysis
Abstract
BACKGROUND: The hypothalamus is a versatile structure comprising several nuclei that play key roles in regulating various biological processes associated with migraine, including hormone secretion, metabolism, circadian rhythm, and autonomic nervous system functions. However, the involvement of hypothalamic subregions in migraine remains unclear.
METHODS: Based on T1-weighted MRI data from 76 migraine patients (23 episodic migraine [EM], 53 chronic migraine [CM]) and 35 healthy controls (HCs), we examined group differences in the volume of five hypothalamic subregions. To clarify causal relationships between migraine and hypothalamic volume, we conducted Mendelian randomization (MR) analyses. Mediation analysis was further performed to assess the role of gut microbiota composition in this association.
RESULTS: Compared to HCs, migraine patients exhibited significantly reduced total hypothalamic volume (813.53 ± 66.46 mm³ vs. 831.86 ± 57.91 mm³; FDR q = 0.048) and inferior tuberal hypothalamic volume (255.26 ± 30.17 mm³ vs. 265.29 ± 23.32 mm³; FDR q = 0.046). These reductions were particularly pronounced in patients with CM, whereas no significant differences were observed in those with EM. MR analysis revealed causal effects of total hypothalamic volumes (OR = 0.80, FDR q = 7.28 × 10-5) and inferior tuberal hypothalamic volumes (OR = 0.85, FDR q = 2.61 × 10-2) on migraine, providing causal evidence to support the observational findings from the cross-sectional study.…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 76 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.